PA-IPF Support Network Launches Innovative Web App

en flag
es flag


 

The Wescoe Foundation for Pulmonary Fibrosis celebrates the success of the PA-IPF Support Network as it approaches its two-year anniversary and launches a new one-of-a-kind web app. Coming off of a successful September Global Pulmonary Fibrosis Awareness Month, we want to thank Senator Browne for his unwavering support in championing our cause, provide a programming update, and offer thought-provoking presentations from pulmonary fibrosis experts.

Where: Coopersburg Borough Hall, 5 North Main Street in Coopersburg, PA

When: Friday, October 21, 2022, at 1:00 p.m.; arrival at 12:30 p.m.

Who: Patients living with IPF, care partners, advocates, policymakers, healthcare professionals, and industry leaders

About the Wescoe Foundation for Pulmonary Fibrosis:
Wescoe Foundation for Pulmonary Fibrosis is a 501(c)3 non-profit organization that provides support, education, advocacy, and resources for patients living with Idiopathic Pulmonary Fibrosis (IPF), as well as their care partners and families, to sustain the highest possible quality of life.

About the PA-IPF Support Network:
Wescoe Foundation for Pulmonary Fibrosis created the only state-wide support network in the United States. It is dedicated to connecting patients living with IPF, their care partners, and healthcare providers to each other as well as to important resources and information.

What is Idiopathic Pulmonary Fibrosis (IPF)?
Pulmonary fibrosis is a rare, incurable lung disease that is characterized by progressive scarring of the lungs. This occurs when air sacs known as alveoli gradually become replaced by fibrotic tissue or scar tissue. As the scar tissue becomes thicker, it leads to stiffness of the lungs, making it difficult to breathe. Pulmonary fibrosis is found in over 200 lung disorders, so it is important for your healthcare provider to identify the cause of the fibrosis because different types of fibrosis respond to different treatments.

 

 

Information Provided By:
Jennifer Wescoe Singley, M.Ed., NCC
Founder, Executive Director
Wescoe Foundation for Pulmonary Fibrosis